Thieler Law Corp, member of the Investor Attorney Network, is investigating whether certain officers and directors of Amedisys Inc (NASDAQ: AMED) violated securities laws in connection with certain financial statements.

The investigation seeks to discover if possible claims on behalf of purchasers of the securities of Amedisys Inc (NASDAQ: AMED) concerning whether a series of statements by Amedisys Inc regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

On May 28, 2015, Amedisys Inc announced in an SEC filing that, "on May 21, 2015, it received a Subpoena Duces Tecum ("Subpoena") issued by the U.S. Department of Justice. The Subpoena requests the delivery of information regarding 53 identified hospice patients to the United States Attorney's Office for the District of Massachusetts. It also requests the delivery of documents relating to the Company's hospice clinical and business operations and related compliance activities. The Subpoena generally covers the period from January 1, 2011, through the present."

Following the release of this news, shares of Amedisys dropped $1.14 per share, to 30.69, or more than 3.58%, on May 29, 2015.

Based in Baton Rouge, LA and founded in 1982, Amedisys Inc, through its subsidiaries, provides home health and hospice care services.  The Company currently owns and operates 316 Medicare-certified home health care centers and 80 Medicare-certified hospice care centers in 34 states within the United States, the District of Columbia, and Puerto Rico.

If you purchased shares of Amedisys Inc (NASDAQ: AMED) on or before May 28, 2015, you should contact Thieler Law Corp at mail@thielerlaw.com or call +1 (619) 377 - 4324.

Thieler Law Corp

2534 State Street - Suite 406,

San Diego, CA 92101

by

email: mail@thielerlaw.com 

or

telephone at +1 (619) 377 - 4324

or

visit our website http://www.thielerlaw.com/ 

or

Facsimile: +1 (619) 785 – 3185